HBA announces 2018 advisory board

The HBA is pleased to announce its 2018 advisory board an invited group of senior industry executives that provide strategic support to help the HBA boldly advance its mission as a united force for change advocating for gender parity.

  • Peter Anastasiou, executive vice president and head of North America, Lundbeck
  • Ruth Brinkley, president of Kaiser Permanente Hospitals Northwest region, Kaiser Permanente
  • Paula Brown Stafford, managing director, Habergeon LLC
  • Nick Colucci, executive chairman, Publicis Health, and COO, Publicis Communications North America
  • Joaquin Duato, EVP and worldwide chairman, pharmaceuticals, Johnson & Johnson
  • Lisa George, VP, global talent for international, Walmart
  • Julie Gerberding, EVP strategic communications, global public policy and population health and chief patient officer, Merck & Co., Inc.
  • Geno Germano, board of directors, Bioverativ Inc.
  • Brian Goff, chief commercial officer, Alexion
  • Murdo Gordon, chief commercial officer, BMS
  • Adele Gulfo, past EVP and chief strategy officer, Mylan
  • Bahija Jallal, president, MedImmune
  • Jacopo Leonardi, chairman and CEO, ActivCore
  • Christine Miller, VP, US development PM, portfolio and launch, Sandoz US
  • Carol Montandon, chief quality officer, vice president quality and compliance, Johnson & Johnson
  • Terri Pascarelli, chief executive officer, AIT Bioscience, LLC
  • Mary Pittman, DrPH, president and CEO, Public Health Institute (PHI)
  • Pam Puryear, senior vice president, chief talent officer, Pfizer, Inc
  • Kim Ramko, Americas advisory life sciences sector lead, EY
  • Kevin Rigby, principal, Rigby Consulting LLC
  • Shideh Sedgh Bina, founding partner, Insigniam
  • Christi Shaw, senior VP, Lilly, and president global bio medicines, Eli Lilly
  • Tim Zuber, partner, KPMG